Drug Type Small molecule drug |
Synonyms GA-2701, Norgesic, Norgesic Forte |
Mechanism A1R antagonists(Adenosine A1 receptor antagonists), A2aR antagonists(Adenosine A2a receptor antagonists), COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization GALT Pharmaceuticals LLCStartup |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (04 Mar 1964), |
Regulation- |
Molecular FormulaC9H8O4 |
InChIKeyBSYNRYMUTXBXSQ-UHFFFAOYSA-N |
CAS Registry50-78-2 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Musculoskeletal Pain | US | 04 Mar 1964 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tension-Type Headache | Preclinical | US | GALT Pharmaceuticals LLCStartup | 28 Jun 2024 |